DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Darvon-N (Propoxyphene Napsylate) - Side Effects and Adverse Reactions

 
 



ADVERSE REACTIONS

In hospitalized patients, the most frequently reported were dizziness, sedation, nausea, and vomiting. Other adverse reactions include constipation, abdominal pain, skin rashes, lightheadedness, headache, weakness, euphoria, dysphoria, hallucinations, and minor visual disturbances.

The most frequently reported postmarketing adverse events have included completed suicide, accidental and intentional overdose, drug dependence, cardiac arrest, coma, drug ineffective, drug toxicity, nausea, respiratory arrest, cardio-respiratory arrest, death, vomiting, dizziness, convulsion, confusional state, and diarrhea.

Additional adverse experiences reported through postmarketing surveillance include:

Cardiac disorders: arrhythmia, bradycardia, cardiac/respiratory arrest, congestive arrest, congestive heart failure (CHF), tachycardia, myocardial infarction (MI)

Eye disorder: eye swelling, vision blurred

General disorder and administration site conditions: drug ineffective, drug interaction, drug tolerance, influenza type illness, drug withdrawal syndrome

Gastrointestinal disorder: gastrointestinal bleed, acute pancreatitis

Hepatobiliary disorder: hepatic steatosis, hepatomegaly, hepatocellular injury

Immune system disorder: hypersensitivity

Injury poisoning and procedural complications: drug toxicity, hip fracture, multiple drug overdose, narcotic overdose

Investigations: blood pressure decreased, heart rate elevated/abnormal

Metabolism and nutrition disorder: metabolic acidosis

Nervous system disorder: ataxia, coma, dizziness, somnolence, syncope

Psychiatric: abnormal behavior, confusional state, hallucinations, mental status change

Respiratory, thoracic, and mediastinal disorders: respiratory depression, dyspnoea

Skin and subcutaneous tissue disorder: rash, itch

Liver dysfunction has been reported in association with Darvon-N. Propoxyphene therapy has been associated with abnormal liver function tests and, more rarely, with instances of reversible jaundice (including cholestatic jaundice).

Subacute painful myopathy has been reported following chronic propoxyphene overdosage.



REPORTS OF SUSPECTED DARVON-N SIDE EFFECTS / ADVERSE REACTIONS

Below is a sample of reports where side effects / adverse reactions may be related to Darvon-N. The information is not vetted and should not be considered as verified clinical evidence.

Possible Darvon-N side effects / adverse reactions in 84 year old female

Reported by a consumer/non-health professional from Canada on 2012-01-27

Patient: 84 year old female

Reactions: Wrong Drug Administered, Product Label Confusion

Adverse event resulted in: death

Suspect drug(s):
MS Contin
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Darvon-N
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication



Possible Darvon-N side effects / adverse reactions in 84 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-01-31

Patient: 84 year old female

Reactions: Wrong Drug Administered, Product Label Confusion

Adverse event resulted in: death

Suspect drug(s):
MS Contin
    Dosage: 60 mg, unk
    Administration route: Oral

Darvon-N
    Administration route: Oral



See index of all Darvon-N side effect reports >>

Drug label data at the top of this Page last updated: 2009-10-27

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017